摘要：
2026年2月6日, 北京大学药学院天然药物及仿生药物全国重点实验室吕万良教授团队在国际学术期刊ACS Nano在线发表了题为A recombinant targeted bionanoparticle in vitro expressing a gene-editing protein for epidermal growth factor receptor mutant lung cancer的研究工作。
Supporting:
北京大学药学院天然药物及仿生药物全国重点实验室. 吕万良团队研究了一种体外表达基因编辑蛋白的重组靶向性生物纳米粒用于表皮生长因子受体突变型肺癌治疗[J]. 中国药学(英文版), 2026, 35(3): 327-327.
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Wanliang Lu studied a recombinant targeted biological nanoparticle for in vitro expression of gene-editing proteins for epidermal growth factor receptor mutant lung cancer[J]. Journal of Chinese Pharmaceutical Sciences, 2026, 35(3): 327-327.
>
>